Target Information
Founded in 2019, amoseeds launched its first product: organic chia seeds. The company's mission to make revitalizing foods accessible has been met with significant success, enabling it to develop an extensive portfolio of over 50 products, which includes a range of superfoods and dietary supplements. amoseeds focuses on high-quality offerings that resonate with health-conscious consumers.
The brand distinguishes itself through a premium positioning strategy. amoseeds carefully selects its producer partners, ensuring responsible, sustainable sourcing while maintaining complete traceability and transparency. All products are organic and cultivated in natural environments, ensuring high nutritional values along with superior quality and purity. Moreover, amoseeds is deeply committed to customer satisfaction, with a team trained in nutrition to assist consumers in selecting and utilizing their products effectively.
Industry Overview
The health food and dietary supplements industry in France has witnessed robust growth in recent years, fueled by an increasing consumer focus on wellness and nutrition. This trend is propelled by rising awareness of the health benefits associated with superfoods, organic products, and dietary supplements. As consumers become more discerning about their food choices, there is a noticeable shift towards premium and organic offerings.
France's organic food market has expanded substantially, with many consumers preferring certified organic products over conventional options. This shift has benefited companies like amoseeds, which thrive on the growing demand for transparency in sourcing, sustainability practices, and health-oriented food products. The government’s support for organic farming and initiatives to promote healthier diets further bolster this industry.
Moreover, advancements in e-commerce and digital marketing allow these companies to reach a broader audience. Younger generations, in particular, drive the demand for innovative food solutions that align with their values regarding health and environmental sustainability. The shift towards online shopping, accelerated by the pandemic, has made it easier for brands to connect directly with consumers and promote their health-enhancing products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
amoseeds is poised for growth, and the recent funding round of €2.4 million from FPCI Food Invest, managed by Elevation Capital Partners, and FPCI Invest Création 5.0, managed by UI Investissement, reflects investor confidence in the company’s potential. This capital injection will enable amoseeds to enhance its product offerings, expand into new European and international markets, and strengthen its B2B operations.
The funds will also support recruitment efforts, with plans to create 20 new positions at the company’s headquarters in Belfort. By embracing strategic growth and innovation, amoseeds aims to solidify its position as a leader in the premium superfoods and supplements market.
Investor Information
Elevation Capital Partners and UI Investissement, the investors guiding this initiative, are reputable entities in the investment landscape. Elevation focuses on developing growth-stage companies, particularly in food and beverage sectors, leveraging its expertise to offer strategic support and resources. UI Investissement specializes in fostering the growth of unlisted French companies, making it a valuable partner for amoseeds in their expansion efforts.
Marc El Asmar, co-founder of FoodXpert, expressed enthusiasm about supporting amoseeds, highlighting its unique position in the superfoods market and the founders' strong vision. Guillaume Blanchet, a director at UI Investissement, emphasized their commitment to nurturing entrepreneurial talent within regions like Bourgogne-Franche-Comté, reinforcing their dedication to fostering successful business ventures.
View of Dealert
The investment in amoseeds presents a promising opportunity given the company's rapid growth and strong market positioning in the health food sector. The strategic expansion into new markets and product developments could significantly enhance profitability and brand presence. Furthermore, the founders’ commitment to customer satisfaction and quality assurance supports a sustainable growth trajectory.
This investment aligns with broader trends in consumer behavior that prioritize health, wellness, and sustainability, which positions amoseeds well to capitalize on these shifts. With a well-defined strategy and a leadership team passionate about their mission, amoseeds is likely to thrive in a competitive landscape.
Moreover, the involvement of experienced investors such as Elevation Capital Partners and UI Investissement adds a robust layer of strategic guidance and resources that can navigate challenges and unlock further growth potential. Their backing signals confidence in amoseeds' future.
In conclusion, the growth potential of amoseeds, combined with the solid foundation provided by its investor partnerships and market trends, marks it as a worthwhile consideration for investment, suggesting a bright future ahead in the health food industry.
Similar Deals
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
Fonds Ile-de-France Réindustrialisation → HiQuTe Diamond
2025
Fonds Ile-de-France Réindustrialisation, French Tech Seed, TF Participations, Socadif, iXcore → HiQuTe Diamond
2025
FPCI Food Invest, Elevation Capital Partners, UI Investissement
invested in
Amoseeds
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $2M